TransMedics Group (TMDX)
(Delayed Data from NSDQ)
$142.19 USD
-1.74 (-1.21%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $142.07 -0.12 (-0.08%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TMDX 142.19 -1.74(-1.21%)
Will TMDX be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for TMDX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TMDX
TransMedics (TMDX) Just Reclaimed the 20-Day Moving Average
Are You Looking for a Top Momentum Pick? Why TransMedics (TMDX) is a Great Choice
TMDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Trending Stock TransMedics Group, Inc. (TMDX) a Buy Now?
Will TransMedics (TMDX) Gain on Rising Earnings Estimates?
Illumina (ILMN) Q1 Earnings Beat, Adjusted Operating Loss Widens
Other News for TMDX
What's Driving Tandem Diabetes Care Inc's Surprising 15% Stock Rally?
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Analysts Are Bullish on Top Healthcare Stocks: Ocular Therapeutix (OCUL), TransMedics Group (TMDX)
Critical Insights From TransMedics Gr Analyst Ratings: What You Need To Know
The 3 Best Medical Device Stocks to Buy in June 2024